-
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
Tuesday, September 10, 2024 - 4:40pm | 445Incannex Healthcare Inc. (NASDAQ:IXHL), a cannabinoid and psychedelic medicine biotechnology company, announced Tuesday a significant financing agreement with Arena Investors, securing up to $60 million in funding. The deal includes $10 million in convertible notes and a $50 million equity line of...